Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	296.54B
Revenue (ttm)	602.21B
Net Income (ttm)	35.75B
Shares Out	11.65M
EPS (ttm)	2,985.83
PE Ratio	8.52
Forward PE	n/a
Dividend	1,050.00 (4.06%)
Ex-Dividend Date	Nov 24, 2025

Volume	19,290
Average Volume	23,911
Open	25,950
Previous Close	25,850
Day's Range	25,300 - 25,950
52-Week Range	23,100 - 32,200
Beta	0.01
RSI	33.59
Earnings Date	Feb 11, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.